X-Message-Number: 14073
Date: Tue, 11 Jul 2000 13:56:14 -0600
From: Linda Chamberlain <>
Subject: FM-2030 placed into cryostasis 

News Release:
For additional information contact
Linda Chamberlain, Executive Director



WHY BE PART OF THE LAST GENERATION TO DIE BEFORE ANTI-AGING MEDICINE SOLVES
THE
AGING PROBLEM?


FOR IMMEDIATE RELEASE

Scottsdale, AZ, 11 July 2000.    Futurist, lecturer and writer FM-2030 was
placed into cryostasis on July 10, 2000 at the Alcor Life Extension Foundation
in Scottsdale, Arizona.   

FM-2030 was a strong advocate (for three decades) of using cryostasis as a
possible means for saving the lives of individuals who cannot be saved by
current medical technology.   His books include The Upwingers, Optimum One,
Telespheres, and Are You Transhuman?.   He taught futurist classes over the
years at such locations as UCLA and the Smithsonian Institution, and he wrote
articles for major news papers like the New York Times and the Los Angeles
Times.

New surgical techniques being pioneered at Alcor were used for the first time
in the cryoprotection operation for FM-2030.  These resulted in vastly
improved
cryoprotection for this long-time supporter of the cryostasis process as a
potentially life saving, though still experimental, technique.

The Alcor Life Extension Foundation was founded in 1972 as a non-profit,
tax-exempt 501(c)(3) organization, and has 39 patients in cryostasis.   Alcor
is the world's largest provider of professional cryotransport services with
over 500 members who have pre-arranged for cryotransport.  Alcor's Emergency
CryoTransport System (ECS) is a medical-style rescue network patterned after
Emergency Medical System (EMS).  Alcor CryoTransport Technicians, as with EMS
technicians, are remotely advised by on-call physicians who are Alcor members
and/or contract physicians.  

If an individual is successfully placed into cryostasis, there are patient
funds for long term care.  These funds are maintained in an independent
Patient
Care Trust and are invested such that they have traditionally earned at least
double the current costs of keeping patients in cryostasis, providing extra
safety margin against poor investment years.

Can patients in cryostasis be successfully resuscitated, perhaps decades from
now, when new medical breakthroughs can reverse the damage caused by diseases
not currently curable?   The medical and scientific foundations for this are
discussed at length in a new book: Nanomedicine, Volume I, by Robert
Freitas.  
These revolutionary concepts were presented by Ralph Merkle, PhD at the Fourth
Alcor Conference on Life Extension Technologies held in June 2000. 

For more information on the Alcor Life Extension Foundation, see our
website at
<http://www.alcor.org/>www.alcor.org

###

Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=14073